Search images on Google      Product Monograph

Active Ingredients:

• irinotecan (irinotecan sucrose octasulfate), 4.3 MG/ML

DIN: 02467135

Dosage Form(s): SUSPENSION

Route(s) of Administration: INTRAVENOUS

Description: LIPOSOMES FOR INJECTION. SINGLE USE VIAL

Schedule: Prescription

Company: IPSEN BIOPHARMACEUTICALS CANADA INC

ATC:

• L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
• L01C - PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS (ATC, WHO)
• L01CE - (ATC, WHO)
• L01CE02 - IRINOTECAN (WHO)

 

External Links for Onivyde:

Search on Google

• Onivyde side effects
• Onivyde dosage
• irinotecan side effects
• irinotecan dosage